Genmab A/S
CSE:GMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
CSE:GMAB
|
DK |
|
P
|
Post Holdings Inc
SWB:2PO
|
US |
|
P
|
Prysmian SpA
XBER:AEU
|
IT |
|
Y
|
Yara International ASA
SWB:IU2
|
NO |
|
Endeavour Silver Corp
TSX:EDR
|
CA |
|
T
|
Twilio Inc
SWB:TWH
|
US |
|
G
|
Greencore Group PLC
OTC:GNCGY
|
IE |
|
C
|
China Resources Beer Holdings Co Ltd
XMUN:CHK
|
HK |
|
P
|
Polytec Holding AG
VSE:PYT
|
AT |
|
Andritz AG
OTC:ADRZY
|
AT |
|
Energy of Minas Gerais Co
BOVESPA:CMIG4
|
BR |
|
KHD Humboldt Wedag Vermoegensverwaltungs-AG
F:HETA
|
DE |
|
A
|
Amtech Systems Inc
XBER:AS3
|
US |
|
OGE Energy Corp
NYSE:OGE
|
US |
|
Nicox SA
PAR:COX
|
FR |
|
F
|
Ferrari NV
LSE:0RDT
|
IT |
|
Reach PLC
LSE:RCH
|
UK |
|
P
|
PSI Software AG
XBER:PSAN
|
DE |
|
Ardelyx Inc
NASDAQ:ARDX
|
US |
|
T
|
Terna Rete Elettrica Nazionale SpA
OTC:TERRF
|
IT |
|
REALIA Business SA
F:RBS
|
ES |
|
S
|
Southern Energy Corp
LSE:SOUC
|
CA |
|
H
|
Hargreaves Lansdown PLC
DUS:DMB
|
UK |
Bankruptcy Probability
Genmab A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genmab A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
113.4B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genmab A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genmab A/S has total debt of 5.1B DKK. This includes both short-term (0 DKK) and long-term (5.1B DKK) debt.
You can find a full breakdown on its Balance Sheet.
